AMORPHIS PHARMA DEVELOPMENT SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Key data

Status

Active

KRS number

0000760620

REGON

38192563600000

NIP/VAT code

9542799406

VAT registration date

04/01/2019

VAT status

Active

Bankruptcy proceedings

No proceedings

AMORPHIS PHARMA DEVELOPMENT SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Contacts

Registered address

UL. BANKOWA 12, m. 147, 40-007, KATOWICE, POLSKASee on map

Website

Latest events (Record since 23/06/2020)

28/06/2024

Financial statement10 months ago

21/06/2023

Financial statementOne year ago

29/09/2022

Financial statement2 years ago

30/06/2021

Financial statement3 years ago

23/06/2020

Financial statement4 years ago

Incorporation date

30/11/2018

Share capital

5,850.00 PLN

Primary activity

Manufacture of basic pharmaceutical products

Representatives

Representatives rights

No data

Representatives

Chairman of the management boardMARTYNA ELŻBIETA KUBAJCZYK

Business linkages

Price: €14.99 (without VAT)
Premium users: 1.00 credit

Financial report (Okredo)

Price: €14.99 (without VAT)
Premium users: 1.00 credit

People

Representatives

Person	Title
MARTYNA ELŻBIETA KUBAJCZYK	Chairman of the management board

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

Net Profit (zł)

15,359

Net Profit (zł)

15,359

Financial report (Okredo)

Price: €14.99 (without VAT)
Premium users: 1.00 credit

Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%)
Liquidity ratio
Net profitability (%)
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)

2020
478,723
8,769
8,590
1.14
19.43
1.79
520,327
29,541
0
-

2021
312,188
153
153
0.95
14.42
0.05
520,480
21,979
0
-

2022
64,112
15,359
15,359
2.53
50.31
23.96
456,148
3,289
0
-

2022
64,112
15,359
15,359
2.53
50.31
23.96
456,148
3,289
0
-

2022

Turnover (zł)

64,112 zł-79 % *

Profit before tax (zł)

15,359 zł9,939 % *

Net Profit (zł)

15,359 zł9,939 % *

Working capital requirement (%)

2.53 166.32 % *

Liquidity ratio

50.31 248.89 % *

Net profitability (%)

23.96 %47,820.00 % *

Equity (zł)

456,148 zł-12 % *

Current liabilities (zł)

3,289 zł-85 % *

Non current liabilities (zł)

0 zł- *

Non-current Assets (zł)

*over the last year starting selected period

Credit history

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

Credit report

Price: 1.00 credit

Unpaid debts

Creditor/Data source	Debt amount	Debt date	Debt type
-	-	-	-

Debt payment history

Creditor/Data source	Debt amount	Debt date	Payment date	Debt type
-	-	-	-	-

Documents

AMORPHIS PHARMA DEVELOPMENT SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents

Date	Description
28/06/2024	OD 01.01.2023 DO 31.12.2023
21/06/2023	OD 01.01.2022 DO 31.12.2022
29/09/2022	OD 01.01.2021 DO 31.12.2021
30/06/2021	OD 01.01.2020 DO 31.12.2020
23/06/2020	OD 28.06.2018 DO 31.12.2019